INTRODUCTION
It is well established that thyroid hormone is required for pituitary growth hormone (GH) secretion in man and several other mammalian species. Hypothyroidism results in impaired basal and stimulated GH secretion and reduced pituitary GH content, effects overcome by the restoration of euthyroidism (Williams, Maxon, Thorner & Frohman, 1985; Dieguez, Jordan, Harris et al. 1986 ; Root, Shulman, Root & Diamond, 1986 ).
Tri-iodothyronine (T3) has been shown to stimulate GH gene transcription in rats and pituitary tumour cell lines (Oppenheimer, Schwartz, Mariash et al. 1987; Samuels, Aranda, Casanova et al. 1988 ).
However, the stimulatory effect of thyroid hormone on GH is not common to all mammalian species nor is it common to other vertebrate classes. Negative regu¬ lation of GH by thyroid hormone has been demon¬ strated in human (Mulchahey, DiBlasio & Jaffe, 1988) and bovine (Silverman, Kaplan, Grumbach & Miller, 1988) pituitary cells. In birds, hypothyroidism is a potent stimulator of GH secretion, in which exogenous thyroid hormone markedly suppresses GH release (Harvey, 1989) . Thyroid hormone directly inhibits the release of GH from chicken pituitary glands (Harvey, 1990¿) and may therefore block the accumulation of newly synthesized GH in avian species. We have investigated this possibility in the present study by determining the effect of thyroid status on the incorporation of [35S] methionine into immunoprecipitable GH in the chicken pituitary gland.
MATERIALS AND METHODS

Animals
Eight-week-old leghorn cockerels (600-700 g body weight) were maintained in battery cages on a 12 h light : 12 h darkness photoperiod and free access to water and feed; they were between 8 and 10 weeks of age when killed.
Hormones and reagents
Methionine-free Dulbecco's modified Eagle's medium (DMEM) was prepared from powdered DME-deficient medium (Sigma, St Louis, MO, U.S.A.) and supple¬ mented with 40 mmol glutamine/1, 800 pmol leucine/1, 800 pmol lysine/1, 10 mmol Hepes/1, 0-1% (w/v) bovine serum albumin, antibiotic-antimycotic solution (Gibco, Grand Hall, Chadwick, Bolton & Scanes (1975) and Hall & Chadwick (1983) (Harvey, Scanes & Klandorf, 1988) or T3 ( 100 pg/kg) to induce hyperthyroidism (Harvey, 1983 Ramey, Highsmith, Wilfinger & Baldwin (1987 by Laskey & Mills (1975) . Gels were dehydrated in dimethyl sulphoxide (DMSO), impregnated with 2,5-diphenyloxazole (PPO) (both from Sigma), dried and exposed with an intensifying screen at -70°C for 1-2 weeks using Kodak X-OMAT film.
Chicken GH radioimmunoassay (RIA) The concentrations of GH in plasma and in incu¬ bation media and pituitary glands were estimated using an homologous chicken GH RIA as described by Harvey & Scanes (1977) and Harvey (19906 Houston & Goddard, 1988) (Fig 1) . The (Fig. 3) F<0-001) [35S]GH were all significantly altered by the in-vitro treatments (Fig. 4) Control (8) l-8 + 0-2b ll-7 + 0-5c 13-4 + 0-5bc T3 (7) 0-8 + 0-lc 10-3+1-lc 11-2+ l-2d
TRH (7) l-7±0-lb 14-9+l-2b 16-6±l-2b
TRH + T3(7) 0-9 + 0-lc 10-5±0-4c ll-4±0-4cd GRF (7) 3-5 + 0-3a 24-0±0-5a 27-5±0-6a GFR + T, (7) Fig. 4 ); these changes were coincident with an increase in the serum GH concentration (see Table 1 ). Fig. 3 ). Although the metabolic clearance rate of GH has been shown to change with thyroidal state (Harvey, 1989) , the increase in plasma GH levels seen in hypothyroid birds probably results primarily from increased pituitary secretion due to a combination of (1) increased responsiveness to TRH through upregulation of TRH receptors (Harvey & Baidwan, 1990) , (2) reduced hypothalamic inhibitory tone (i.e. decreased somatostatin production; see Harvey, 1989) , (3) increased hypothalamic stimulation (Harvey, 1989) 127-5±23-2a
T, (7) 24-9 + 2-3b 97-5 + 7-5a
122-6 + 8-7a
TRH (7) 25-3 + 3-2b 87-9 + 7-4a 113-3 + 6-7a TRH + T3 (7) 19-0 + 0-9b 80-l±3-8a
GRF (7) 35-9±80a
78-0 + 6-3a
120-8±8-9a
GRF + T3 (7) 30-5 + 5-8a
75-7±8-6a
106-3 + 13-la
Means within a column with the same letter are not significantly (P < 005) different (Duncan's multiple-range test).
See Table 2 for in-vitro culture methods.
and (4) (Harvey & Baidwan, 1990 (Scanes, Klandorf, Carsia & Perez, 1986; Donoghue, Perez, Diamante et al. 1990; Harvey, 1990e (Harvey & Baidwan, 1990 Hall, Harvey & Scanes, 1986) , and there exists considerable evidence for a physio¬ logical role for TRH in the control of GH in avian species (see Harvey, 1990a (Perez, Malamed & Scanes, 1987) . The limited comparisons between TRH and GRF that can be made from the present study suggest that the two secretagogues may exert different effects on GH release and synthesis. The human GRF was highly stimulatory in releasing GH and dramatically increased the total amount of newly synthesized GH (see Fig. 4 ), whereas TRH stimulated release of newly synthesized GH, but it did not alter the total amount of [ S]GH (see Fig. 2 Guillemin, 1986) . GRF has been shown to increase rat GH mRNA levels by increasing the rate of GH gene tran¬ scription (Barinaga, Yamonoto, Rivier et (Dieguez, Foord, Peters et al. 1985; Williams et al. 1985; Dieguez et al. 1986; Root et al. 1986 ). On the other hand, GRF mRNA content in the rat hypothalamus is increased in hypothyroidism and decreased in hyperthyroidism (Jones, Burrin, Ghatei et al. 1990 ). In the chicken, the stimulation by human GRF of release and accumulation of [35S]GH was dramatically reduced by in-vitro exposure to T3 (see Fig. 4 
